PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
- Status
- RECRUITING
- Phase
- PHASE3
Navigating the Clinical Trial Process for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Prognostic Models for HCC Based on Tumor Micronecrosis
- Status
- UNKNOWN
- Phase
- N/A
Improving Hepatocellular Carcinoma Screening
- Status
- RECRUITING
- Phase
- NA
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy
- Status
- RECRUITING
- Phase
- N/A
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
- Status
- RECRUITING
- Phase
- NA
Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies
- Status
- RECRUITING
- Phase
- PHASE1
Prognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on Cirrhosis
- Status
- UNKNOWN
- Phase
- N/A
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Contrast Enhanced Ultrasound (CEUS) in Atypical Liver Nodules in Patients With Chronic Liver Disease
- Status
- COMPLETED
- Phase
- N/A
The Application of Serum DNA Methylation for Patients With HCC
- Status
- RECRUITING
- Phase
- NA